RSC Advances p. 44509 - 44516 (2014)
Update date:2022-07-30
Topics:
Gholivand
Gholami
Tizhoush
Schenk
Fadaei
Bahrami
Two triphenyltin(iv) adducts of difunctional ligands, N-(n-pyridinyl) diphenylphosphinic amide (n = 2 and 4), have been synthesized and characterized by 1H, 31P, 119Sn NMR and IR spectroscopy. The spectroscopic properties of the complexes were compared with those of corresponding ligands. The crystal structures of the complexes were determined by X-ray crystallography, which reveals a trigonal bipyramidal geometry surrounding the tin(iv). Both of the ligands function in an ambidentate mode, ligating through either the O or N atom. The experimental and theoretical (DFT) studies show that the Sn(iv) interacts more strongly with the N-pyridine atom than the PO functional group. Furthermore, DFT calculations, at the B3LYP level, have been carried out to determine the deeper reasons for the adopted bonding mode in the complexes. The influence of the ligand structure on the coordination behaviour and the contribution of hydrogen bonding to the stability of the resulting complexes were elucidated. The results indicate that the intermolecular hydrogen bonds have an important role in the molecular structures and supramolecular associations of the organotin(iv) compounds. This journal is
View MoreSuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Ceresking Ecology & Technology co.,ltd
Contact:86 22 66218397
Address:Room 1613, Zheshang Mansion, No. 1988, Yingbin Avenue, Binhai New District, Tianjin,China.
Xinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Tianjin Hedong Red Cliff Chemical Reagent Factory
Contact:+86-022-84780548
Address:Li Ming Zhuang Gong Ye Yuan,Dongli District,Tianjin,China
Contact:+86-310-7092106
Address:Quzhou Modern & New Industrial Park, Handan, Hebei 057250, China
Doi:10.1016/j.farmac.2003.10.003
(2004)Doi:10.1271/bbb.64.1982
(2000)Doi:10.1081/CAR-100108661
(2001)Doi:10.1016/S0014-827X(99)00049-X
(1999)Doi:10.1055/s-2002-19329
(2002)Doi:10.1016/j.ejmech.2014.09.046
(2014)